Cargando…
Reclassifying TNM stage I/II colorectal cancer into two subgroups with different overall survival, tumor microenvironment, and response to immune checkpoint blockade treatment
Background: The traditional TNM staging system is often insufficient to differentiate the survival discrepancies of colorectal cancer (CRC) patients at TNM stage I/II. Our study aimed to reclassify stage I/II CRC patients into several subgroups with different prognoses and explore their suitable the...
Autores principales: | Liu, Xiangxiang, Qin, Jian, Nie, Junjie, Sun, Huiling, Pan, Yuqin, Wang, Shukui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9532767/ https://www.ncbi.nlm.nih.gov/pubmed/36212126 http://dx.doi.org/10.3389/fgene.2022.948920 |
Ejemplares similares
-
The Predictive Role of Immune Related Subgroup Classification in Immune Checkpoint Blockade Therapy for Lung Adenocarcinoma
por: Yu, Xiaozhou, et al.
Publicado: (2021) -
ANGPTL2+cancer-associated fibroblasts and SPP1+macrophages are metastasis accelerators of colorectal cancer
por: Liu, Xiangxiang, et al.
Publicado: (2023) -
Identification of Serum Exosomal hsa-circ-0004771 as a Novel Diagnostic Biomarker of Colorectal Cancer
por: Pan, Bei, et al.
Publicado: (2019) -
LncRNA SNHG16 promotes colorectal cancer proliferation by regulating ABCB1 expression through sponging miR-214-3p
por: Tan, Pei, et al.
Publicado: (2022) -
The Identification of Metal Ion Ligand-Binding Residues by Adding the Reclassified Relative Solvent Accessibility
por: Hu, Xiuzhen, et al.
Publicado: (2020)